Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU experts fear Council may rush decision on MDD (Medical Devices Directive) review

This article was originally published in Clinica

Executive Summary

A key debate of the medical device regulatory system takes place this week. The EU Health Council is to meet on November 15, when ministers will discuss the ongoing five-year review of the Medical Devices Directive (MDD). Some industry and regulatory experts fear that an over-pessimistic view of the performance of the MDD may be presented at the meeting. If this happens - and if discussion time is monopolised by concerns over bioterrorism -the Council may reach a conclusion that more fundamental changes are needed than are generally considered necessary, thereby overriding the consensus view that minor changes are all that are needed.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT073996

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel